LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Screening and detection of antimicrobials from Dai pharmaceuticals against clinical diseases by methicillin-resistant Staphylococcus aureus.

Photo from wikipedia

Oroxylum indicum is one of valuable Dai pharmaceutical, the dry seeds and bark of O. indicum were used to treat acute cough, sore throat and so on. Of the seven… Click to show full abstract

Oroxylum indicum is one of valuable Dai pharmaceutical, the dry seeds and bark of O. indicum were used to treat acute cough, sore throat and so on. Of the seven compounds from O. indicum were determined and obtained using bioassay-guided method. Among them, compound 7 was obtained from the plant for the first time. Eight bacterial strains and one yeast fungi were exposed to the compounds. Minimum inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs) or minimum fungicidal concentrations (MFCs) were determined according to the standard broth microdilution method. Baicalein (2) exhibited relative strong antibacterial activities with MIC of 8 μg.ml-1 and MBC of 16 μg.ml-1 against three MRSA strains of Staphylococcus aureus of SCCmec III type. While flavonoids 3, 5 and 7 showed some degree of activities against methicillin-susceptible Staphylococcus aureus (MSSA, ATCC25923). The findings may offer new evidences that why O. indicum was used widely in Dai peoples' life.

Keywords: staphylococcus; antimicrobials dai; staphylococcus aureus; screening detection; detection antimicrobials

Journal Title: Letters in applied microbiology
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.